Skip to main content
Equibles

Brian Brown

CFO

Co-Diagnostics, Inc. (CODX)

Equibles does not estimate personal net worth.

About Brian Brown

Brian Brown is recorded as CFO at Co-Diagnostics, Inc. (CODX). The newest filing on record that lists Brian Brown as CFO at Co-Diagnostics, Inc. (CODX) is dated July 21, 2026. The proxy statement of Co-Diagnostics, Inc. reports total compensation of $421,250 for Brian Brown in fiscal 2025, including a base salary of $320,000. Disclosed compensation is on record for 5 fiscal years. Brian Brown has spoken on 21 earnings calls across 1 company, most recently for Co-Diagnostics, Inc. on May 14, 2026. Co-Diagnostics, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Co-Diagnostics, Inc. includes Dwight H Egan (CEO), Brian L. Brown, CPA (CFO), Daniel Bohrer (Chief Accounting Officer) and 4 others.

Brian Brown on recent calls

“For the first quarter of 2026, total revenue was $146,000 compared to $50,000 in the same period last year. Cost of revenue for the quarter was $194,000, resulting in a loss of approximately $48,000 compared to a gross profit of $29,000 in the prior year period.”
CFO, Co-Diagnostics, Inc. Q1 FY2026 Earnings Call ·
“For the full year 2025, total revenue was $0.6 million compared to $3.9 million in 2024. The year-over-year decrease was primarily driven by lower grant revenue, as most of the previously awarded grant funding was recognized in the prior year.”
CFO, Co-Diagnostics, Inc. Q4 FY2025 Earnings Call ·
“For the quarter, total revenue was $0.1 million compared to $0.6 million in the same period last year. In the prior year period, revenue from grants represented approximately $0.4 million, while in Q3 2025, all revenue recognized came from product sales.”
CFO, Co-Diagnostics, Inc. Q3 FY2025 Earnings Call ·
“For the second quarter of 2025, total revenue decreased to $0.2 million as compared to $2.7 million in the prior year same period. In the prior year same period, revenue from grants represented $2.5 million, while all revenue recognized during the second quarter of 2025 came from product sales.”
CFO, Co-Diagnostics, Inc. Q2 FY2025 Earnings Call ·
“For the first quarter of 2025 total revenue decreased to $0.1 million, as compared to $0.5 million in the prior year's same period. All revenue recognition during the first quarter came from product revenue.”
CFO, Co-Diagnostics, Inc. Q1 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Co-Diagnostics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Co-Diagnostics, Inc. (CODX) $320,000 $421,250
2024 Co-Diagnostics, Inc. (CODX) $313,333 $578,083
2023 Co-Diagnostics, Inc. (CODX) $300,000 $1,033,550
2022 Co-Diagnostics, Inc. (CODX) $280,875 $1,577,772
2021 Co-Diagnostics, Inc. (CODX) $209,731 $2,153,138

Recent activity

Show 9 earlier activities